Clinical Trial Update: Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients. [Phase 2]

View source ↗

Summary

Phase 2 efficacy study evaluating a pioglitazone and ramipril combination in non-diabetic hypertensive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Ramipril (ramipril)

Snippet

Sponsor: Takeda | Conditions: Inflammation, Hypertension | Phase 2 | Status: COMPLETED